Labelling of small biomolecules using novel technetium-99m cores

by International Atomic Energy Agency

2007 311 pages eng

Technetium-99m radiopharmaceuticals account for nearly 80% of all diagnostic studies done in nuclear medicine. The ability to determine the exact molecular structure of the coordination compounds by using modern powerful analytical tools such as NMR, mass spectroscopy and X ray diffraction has contr…